PRICE T ROWE ASSOCIATES INC /MD/ - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 51 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$14,000
-33.3%
18,2000.0%0.00%
Q2 2022$21,000
-43.2%
18,2000.0%0.00%
Q1 2022$37,000
-28.8%
18,2000.0%0.00%
Q4 2021$52,000
-32.5%
18,2000.0%0.00%
Q3 2021$77,000
-38.4%
18,200
-22.9%
0.00%
Q2 2021$125,000
-12.0%
23,600
-22.6%
0.00%
Q1 2021$142,000
+40.6%
30,5000.0%0.00%
Q4 2020$101,000
-76.3%
30,500
-76.4%
0.00%
Q3 2020$427,000
-1.8%
129,0000.0%0.00%
Q2 2020$435,000
+2.4%
129,000
+16.2%
0.00%
Q1 2020$425,000
+1.0%
111,048
+59.2%
0.00%
Q4 2019$421,000
+194.4%
69,748
+269.1%
0.00%
Q3 2019$143,000
-73.8%
18,898
-53.0%
0.00%
Q2 2019$545,000
-9.9%
40,192
-64.0%
0.00%
Q1 2019$605,000
+395.9%
111,600
+170.9%
0.00%
Q4 2018$122,000
-79.1%
41,200
-42.5%
0.00%
Q3 2018$584,000
+3.0%
71,600
+23.0%
0.00%
Q2 2018$567,000
+56.6%
58,200
+39.7%
0.00%
Q1 2018$362,000
-30.5%
41,655
+0.1%
0.00%
Q4 2017$521,00041,6320.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
RA Capital Management 507,191$5,107,0000.50%
Cormorant Asset Management, LP 356,600$3,591,0000.43%
Perceptive Advisors 558,446$5,623,0000.42%
NEXTHERA CAPITAL LP 15,000$151,0000.21%
EMERALD ADVISERS, LLC 237,070$2,387,0000.11%
AUXIER ASSET MANAGEMENT 17,857$180,0000.04%
FEDERATED HERMES, INC. 450,000$4,532,0000.01%
Nationwide Fund Advisors 49,473$498,0000.00%
Catalyst Capital Advisors LLC 348$4,0000.00%
DEUTSCHE BANK AG\ 859$8,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders